These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14503109)

  • 21. Analogous comparison of registered brand name drugs of tablets and capsules commercially available in Thailand: A retrospective study.
    Napaporn J; Buakaew P; Suksakornthanawat P; Sripa S; Jinatongthai P; Supapaan T
    PLoS One; 2022; 17(10):e0276321. PubMed ID: 36260612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution Failure of Solid Oral Drug Products in Field Alert Reports.
    Sun D; Hu M; Browning M; Friedman RL; Jiang W; Zhao L; Wen H
    J Pharm Sci; 2017 May; 106(5):1302-1309. PubMed ID: 28104414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy and completeness of drug information in Wikipedia medication monographs.
    Reilly T; Jackson W; Berger V; Candelario D
    J Am Pharm Assoc (2003); 2017; 57(2):193-196.e1. PubMed ID: 27866956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of herbal and dietary supplement references.
    Sweet BV; Gay WE; Leady MA; Stumpf JL
    Ann Pharmacother; 2003 Apr; 37(4):494-9. PubMed ID: 12659602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse-drug-event data provided by pharmaceutical companies.
    Cudny ME; Graham AS
    Am J Health Syst Pharm; 2008 Jun; 65(11):1071-5. PubMed ID: 18499882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of resources for analyzing drug interactions.
    Patel RI; Beckett RD
    J Med Libr Assoc; 2016 Oct; 104(4):290-295. PubMed ID: 27822150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of vitamin and mineral tablets and capsules on the Canadian market.
    Löbenberg R; Steinke W
    J Pharm Pharm Sci; 2006; 9(1):40-9. PubMed ID: 16849007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Access to prescribing information for paediatric medicines in the USA: post-modernization.
    Young L; Lawes F; Tordoff J; Norris P; Reith D
    Br J Clin Pharmacol; 2009 Mar; 67(3):341-6. PubMed ID: 19220278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of bead sizes for MR capsules labeled for sprinkle.
    Nagavelli LR; Lionberger RA; Sayeed VA; Yu L; Allgire J; Smith A; Wokovich A; Westenberger BJ; Buhse L
    AAPS PharmSciTech; 2010 Dec; 11(4):1508-10. PubMed ID: 20936439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Over-the-counter pharmaceuticals: exploratory research of consumer preference toward solid oral dosage forms.
    Reisenwitz TH; Wimbish GJ
    Health Mark Q; 1996; 13(4):47-61. PubMed ID: 10159645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs via enteral feeding tubes in inpatients: dispersion analysis and safe use of dispensers.
    Beserra MPP; De Oliveira CLCG; Portela MP; Lopes MVO; Fonteles MMF
    Nutr Hosp; 2017 Mar; 34(2):257-263. PubMed ID: 28421776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of an inspection-supporting system using drug images for unit dose packages].
    Takayama K; Seino T; Sugiura M; Yamamura Y; Nakamura H; Sato H; Yamada Y; Iga T
    Yakugaku Zasshi; 2001 Nov; 121(11):821-8. PubMed ID: 11725551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics and trends of drug and dietary supplement inquiries by college athletes.
    Ambrose PJ; Tsourounis C; Uryasz FD; Patterson E
    J Am Pharm Assoc (2003); 2013; 53(3):297-303. PubMed ID: 23699678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indexable imprinting of solid dosage forms.
    Collier WA
    Drug Intell Clin Pharm; 1977 Mar; 11(3):170-5. PubMed ID: 10235794
    [No Abstract]   [Full Text] [Related]  

  • 37. Crushing tablets or opening capsules: many uncertainties, some established dangers.
    Prescrire Int; 2014 Sep; 23(152):209-11, 213-4. PubMed ID: 25325120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal drug dosing recommendations: evaluation of product information for brands of the same drug.
    Khanal A; Peterson GM; Castelino RL; Jose MD
    Intern Med J; 2014 Jun; 44(6):591-6. PubMed ID: 24946814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissolution testing of orally disintegrating tablets.
    Kraemer J; Gajendran J; Guillot A; Schichtel J; Tuereli A
    J Pharm Pharmacol; 2012 Jul; 64(7):911-8. PubMed ID: 22686339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in Adverse Event Reporting Rates of Therapeutic Failure Between Two Once-daily Extended-release Methylphenidate Medications in Canada: Analysis of Spontaneous Adverse Event Reporting Databases.
    Park-Wyllie L; van Stralen J; Castillon G; Sherman SE; Almagor D
    Clin Ther; 2017 Oct; 39(10):2006-2023. PubMed ID: 28988700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.